Arylsulfonamides and uses as hydroxysteroid dehydrogenase

Details for Australian Patent Application No. 2005250336 (hide)

Owner Amgen, Inc.

Inventors Degraffenreid, Michael R.; Sun, Daqing; Powers, Jay P.; Yan, Xuelei

Agent Shelston IP

Pub. Number AU-B-2005250336

PCT Pub. Number WO2005/118538

Priority 60/564,376 20.04.04 US

Filing date 20 April 2005

Wipo publication date 15 December 2005

Acceptance publication date 9 June 2011

International Classifications

C07D 209/00 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/401 (2006.01) - Proline

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/404 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/47 (2006.01) - Quinolines

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 207/48 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 215/58 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 217/08 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 295/26 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/118538 Priority application(s): WO2005/118538

9 June 2011 Application Accepted

  Published as AU-B-2005250336

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250341-Antibodies to angiogenesis inhibiting domains of CD148

2005250333-Omi PDZ modulators